Spine surgeon Daniel Park, MD, completed the first U.S. case using Kuros Biosciences’ MagnetOs minimally invasive surgery delivery system, according to an Aug. 5 news release.
MagnetOs MIS, a bone graft delivery system, was cleared by the FDA in May. Compared to a traditional funnel-based system, Magnet OS MIS completed graft placement three times faster.
“MagnetOs MIS delivered smooth, precise graft placement in a typically challenging MIS TLIF case — no preparation, no thawing, just immediate delivery and efficiency,” Dr. Park said in the release. “It pairs streamlined handling with compelling clinical data, making it a meaningful advancement for surgeons who value both efficiency and biologically robust healing.”
A full commercial release is expected for the Fall.
